Sunitinib Accord 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Harmonet Tafla 75 míkróg+ 20 míkróg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

harmonet tafla 75 míkróg+ 20 míkróg

pfizer aps (p) - gestodenum inn; ethinylestradiolum inn - tafla - 75 míkróg+ 20 míkróg

CitraFleet Mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

citrafleet mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g

casen recordati s.l. - natrii picosulfas inn; magnesii oxidum; citric acid - mixtúruduft, lausn í skammtapoka - 10,0 mg/3,5 g/10,97 g